263 related articles for article (PubMed ID: 30999005)
21. The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors.
De Martino M; Pellecchia S; Esposito F; Tosti N; Quintavalle C; Eppenberger-Castori S; Carafa V; Righi A; Chieffi P; Fusco A; Terracciano LM; Pallante P
Cell Cycle; 2022 Jun; 21(12):1335-1346. PubMed ID: 35282770
[TBL] [Abstract][Full Text] [Related]
22. Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors.
Wen S; Li J; Yang J; Li B; Li N; Zhan X
Front Endocrinol (Lausanne); 2021; 12():753606. PubMed ID: 34712204
[TBL] [Abstract][Full Text] [Related]
23. Transcriptomic analysis identifies a tumor subtype mRNA classifier for invasive non-functioning pituitary neuroendocrine tumor diagnostics.
Bao X; Wang G; Yu S; Sun J; He L; Zhao H; Ma Y; Wang F; Wang X; Wang R; Yu J
Theranostics; 2021; 11(1):132-146. PubMed ID: 33391466
[No Abstract] [Full Text] [Related]
24. HMGA2 cooperates with either p27
Fedele M; Paciello O; De Biase D; Monaco M; Chiappetta G; Vitiello M; Barbieri A; Rea D; Luciano A; Papparella S; Arra C; Fusco A
Cell Cycle; 2018; 17(5):580-588. PubMed ID: 29157111
[TBL] [Abstract][Full Text] [Related]
25. RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins.
D'Angelo D; Mussnich P; Sepe R; Raia M; Del Vecchio L; Cappabianca P; Pellecchia S; Petrosino S; Saggio S; Solari D; Fraggetta F; Fusco A
J Mol Med (Berl); 2019 Jul; 97(7):1019-1032. PubMed ID: 31076808
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of high mobility group A proteins in lung cancer.
Sarhadi VK; Wikman H; Salmenkivi K; Kuosma E; Sioris T; Salo J; Karjalainen A; Knuutila S; Anttila S
J Pathol; 2006 Jun; 209(2):206-12. PubMed ID: 16521118
[TBL] [Abstract][Full Text] [Related]
27. Identification of cholesterol metabolism-related subtypes in nonfunctioning pituitary neuroendocrine tumors and analysis of immune infiltration.
Feng T; Hou P; Mu S; Fang Y; Li X; Li Z; Wang D; Chen L; Lu L; Lin K; Wang S
Lipids Health Dis; 2023 Aug; 22(1):127. PubMed ID: 37563740
[TBL] [Abstract][Full Text] [Related]
28. HMGA1/HMGA2 protein expression and prognostic implications in gastric cancer.
Jun KH; Jung JH; Choi HJ; Shin EY; Chin HM
Int J Surg; 2015 Dec; 24(Pt A):39-44. PubMed ID: 26537313
[TBL] [Abstract][Full Text] [Related]
29. CXCL12-regulated miR-370-3p functions as a tumor suppressor gene by targeting HMGA2 in nonfunctional pituitary adenomas.
Cai F; Dai C; Chen S; Wu Q; Liu X; Hong Y; Wang Z; Li L; Yan W; Wang R; Zhang J
Mol Cell Endocrinol; 2019 May; 488():25-35. PubMed ID: 30853598
[TBL] [Abstract][Full Text] [Related]
30. 6p21 rearrangements in uterine leiomyomas targeting HMGA1.
Nezhad MH; Drieschner N; Helms S; Meyer A; Tadayyon M; Klemke M; Belge G; Bartnitzke S; Burchardt K; Frantzen C; Schmidt EH; Bullerdiek J
Cancer Genet Cytogenet; 2010 Dec; 203(2):247-52. PubMed ID: 21156240
[TBL] [Abstract][Full Text] [Related]
31. Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.
Kara M; Tokat F; Pamir MN; Danyeli AE
Endocr Pathol; 2020 Jun; 31(2):166-173. PubMed ID: 32157655
[TBL] [Abstract][Full Text] [Related]
32. Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Awad S; Dorward N; Grieve J; Mendoza N; Muquit S; Grossman AB; Balkwill F; Korbonits M
Acta Neuropathol Commun; 2019 Nov; 7(1):172. PubMed ID: 31703742
[TBL] [Abstract][Full Text] [Related]
33. Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors.
Wang L; Wei C; Wang Y; Huang N; Zhang T; Dai Y; Xue L; Lin S; Wu ZB
Front Endocrinol (Lausanne); 2023; 14():1149997. PubMed ID: 37534217
[TBL] [Abstract][Full Text] [Related]
34. RPSAP52 lncRNA Inhibits p21Waf1/CIP Expression by Interacting With the RNA Binding Protein HuR.
D'Angelo D; Arra C; Fusco A
Oncol Res; 2020 Mar; 28(2):191-201. PubMed ID: 31831098
[TBL] [Abstract][Full Text] [Related]
35. The HMGA proteins: a myriad of functions (Review).
Cleynen I; Van de Ven WJ
Int J Oncol; 2008 Feb; 32(2):289-305. PubMed ID: 18202751
[TBL] [Abstract][Full Text] [Related]
36. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
[TBL] [Abstract][Full Text] [Related]
37. [Expression of high mobility group protein A in male mouse testicular cell lines].
Ma ZB; Yang Y; Wang J; Li L
Zhonghua Nan Ke Xue; 2009 Jun; 15(6):534-7. PubMed ID: 19593995
[TBL] [Abstract][Full Text] [Related]
38. Differential expression levels of β-catenin are associated with invasive behavior of both functional and non-functional pituitary neuroendocrine tumor (PitNET).
Taghavi SF; Ghorbani M; Panahi M; Nazem S; Karimi M; Salimi V; Tavakoli-Yaraki M
Mol Biol Rep; 2023 Aug; 50(8):6425-6434. PubMed ID: 37326745
[TBL] [Abstract][Full Text] [Related]
39. The high-mobility group A1-estrogen receptor β nuclear interaction is impaired in human testicular seminomas.
Esposito F; Boscia F; Gigantino V; Tornincasa M; Fusco A; Franco R; Chieffi P
J Cell Physiol; 2012 Dec; 227(12):3749-55. PubMed ID: 22392906
[TBL] [Abstract][Full Text] [Related]
40. Role of High-mobility Group Protein A Isoforms and Their Clinicopathologic Significance in Primary Retinoblastoma.
Singh MK; Singh L; Sen S; Pushker N; Sharma A; Ahamad FC; Chawla B; Kashyap S
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):244-250. PubMed ID: 26657872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
